Publication | Closed Access

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

PsychiatryAddictionPsychotropic MedicationChronic Suicidal IdeationSuicidePsychopharmacologyPsychologyNeuropharmacologyDepressionRepeat-dose Ketamine AugmentationSocial SciencesMental HealthRelapse PreventionMedicinePsychopathologyDouble Blind